EUVIMEDScopri EUVIMED
Crossref

Enhancing Cellular Immunity Through Epitope Peptides of SARS-CoV-2 in Individuals with Specific HLA Allele

Xinliang Huang, Yunyun Wu, Fangliu Yu, Bohan Dong, Zhu Yang

Cellular Physiology and Biochemistry · 2025

DOI: 10.33594/000000768 ↗

At a glance

Journal article in Cellular Physiology and Biochemistry, 2025. Written by Xinliang Huang and 4 co-authors. Institution: Department of Medical Microbiology and Immunology, Wannan Medical College, Wuhu City, Anhui Province, 241000, China. Major MEDLINE topics: SARS-CoV-2, Epitopes, T-Lymphocyte, COVID-19, Immunity, Cellular. Funded by: Anhui Provincial Department of Education Natural Science Research Project Major Project, Anhui Provincial Department of Education Natural Science Research Project Key Project, Wuhu Science and Technology Program.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background/Aims: This research explores the effectiveness of a new cytotoxic T-cell epitope peptide specific for HLA-A2402 in enhancing cellular immune responses to SARS-CoV-2 infections. HLA molecules play a key role in presenting antigenic epitopes to T cells, with genetic polymorphisms resulting in varying immune responses among individuals. The study aimed to investigate whether loading this epitope peptide into dendritic cells (DCs) from HLA-A2402(+) individuals could improve immune responses.

Methods

DCs were sensitized with varying doses of the peptide (2–12 µg/mL), with optimal results observed at 8 µg/mL. T-cell responses, proliferation, differentiation, Th cytokine secretion, CTL function, and apoptotic response were compared among the HLA-A2402(+), HLA-A2402(-), PBS control, DC only, and epitope-only groups.

Results

A significant enhancement in DC maturation, antigen presentation, T-cell activation, and proliferation was observed in the HLA-A2402(+) group compared to the HLA-A2402(-) control.

Conclusion

These findings suggest that HLA-A2402-restricted epitope peptides can enhance cellular immunity, offering potential for improving allele-specific SARS-CoV-2 vaccines and other molecular therapies, advancing precision medicine for infectious diseases.

Subjects

MeSH terms (MEDLINE)

SARS-CoV-2Epitopes, T-LymphocyteCOVID-19Immunity, CellularPeptidesHumansDendritic CellsAllelesCell ProliferationT-Lymphocytes, CytotoxicLymphocyte ActivationAntigen PresentationCytokines

Author keywords

Sars-CoV-2; Epitope peptide; Dendritic cells; Cellular immunity

Substances

Epitopes, T-LymphocytePeptidesCytokines

Authors and institutions

  • Department of Medical Microbiology and Immunology, Wannan Medical College, Wuhu City, Anhui Province, 241000, China.
  • Department of Medical Microbiology and Immunology, Wannan Medical College, Wuhu City, Anhui Province, 241000, China, zhuyang@wnmc.edu.cn.

Funding

  • Anhui Provincial Department of Education Natural Science Research Project Major Project
  • Anhui Provincial Department of Education Natural Science Research Project Key Project
  • Wuhu Science and Technology Program
  • Wannan Medical College Scientific Research Project

Cite

APA

Huang, X., Wu, Y., Yu, F., Dong, B., & Yang, Z. (2025). Enhancing Cellular Immunity Through Epitope Peptides of SARS-CoV-2 in Individuals with Specific HLA Allele. Cellular Physiology and Biochemistry. https://doi.org/10.33594/000000768

Vancouver

Huang X, Wu Y, Yu F, Dong B, Yang Z. Enhancing Cellular Immunity Through Epitope Peptides of SARS-CoV-2 in Individuals with Specific HLA Allele. Cellular Physiology and Biochemistry. 2025. doi:10.33594/000000768

BibTeX
@article{Huang2025,
  author = {Huang, Xinliang and Wu, Yunyun and Yu, Fangliu and Dong, Bohan and Yang, Zhu},
  title = {Enhancing Cellular Immunity Through Epitope Peptides of SARS-CoV-2 in Individuals with Specific HLA Allele},
  journal = {Cellular Physiology and Biochemistry},
  year = {2025},
  doi = {10.33594/000000768}
}
Start for free →